These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 31353)

  • 21. [Tardive dystonia--a case report on therapy and metaphylaxis].
    Genz A
    Psychiatr Neurol Med Psychol (Leipz); 1988 May; 40(5):264-8. PubMed ID: 2905065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The behavioral toxicity of bromocriptine in patients with psychiatric illness.
    Perovich RM; Lieberman JA; Fleischhacker WW; Alvir J
    J Clin Psychopharmacol; 1989 Dec; 9(6):417-22. PubMed ID: 2574194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sulpiride-induced tardive dystonia.
    Miller LG; Jankovic J
    Mov Disord; 1990; 5(1):83-4. PubMed ID: 1967484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molindone and haloperidol in tardive dyskinesia.
    Glazer WM; Hafez HM; Benarroche CL
    J Clin Psychiatry; 1985 Aug; 46(8 Pt 2):4-7. PubMed ID: 2862139
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of clozapine-associated tardive dyskinesia.
    Lin CC; Bai YM; Chen JY; Wang YC; Liou YJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):599-600. PubMed ID: 17920744
    [No Abstract]   [Full Text] [Related]  

  • 26. Antipsychotic agents: a review.
    Dilsaver SC
    Am Fam Physician; 1993 Jan; 47(1):199-204. PubMed ID: 8418582
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Behavioral interactions induced by chronic neuroleptic therapy in persons with mental retardation.
    Schroeder SR; Gualtieri CT
    Psychopharmacol Bull; 1985; 21(2):310-5. PubMed ID: 2860695
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment outcome with clozapine in tardive dyskinesia, neuroleptic sensitivity, and treatment-resistant psychosis.
    Small JG; Milstein V; Marhenke JD; Hall DD; Kellams JJ
    J Clin Psychiatry; 1987 Jul; 48(7):263-7. PubMed ID: 2885310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Neuroleptic-induced movement disorders: historical perspectives].
    Wolf MA; Yassa R; Llorca PM
    Encephale; 1993; 19(6):657-61. PubMed ID: 12404786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Withdrawal symptoms after long-term treatment with low-potency neuroleptics.
    Chouinard G; Bradwejn J; Annable L; Jones BD; Ross-Chouinard A
    J Clin Psychiatry; 1984 Dec; 45(12):500-2. PubMed ID: 6150030
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroleptic discontinuation syndromes.
    Tranter R; Healy D
    J Psychopharmacol; 1998; 12(4):401-6. PubMed ID: 10065916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anticholinergic challenge and neuroleptic withdrawal. Changes in dyskinesia and symptom measures.
    Gardos G; Cole JO; Rapkin RM; LaBrie RA; Baquelod E; Moore P; Sovner R; Doyle J
    Arch Gen Psychiatry; 1984 Nov; 41(11):1030-5. PubMed ID: 6149737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discontinuation of antipsychotic drug therapy.
    Mitchell JE
    Psychosomatics; 1981 Mar; 22(3):241-7. PubMed ID: 6111827
    [No Abstract]   [Full Text] [Related]  

  • 34. Respiratory dyskinesia and dysarthria from prolonged neuroleptic use: tardive dyskinesia?
    Faheem AD; Brightwell DR; Burton GC; Struss A
    Am J Psychiatry; 1982 Apr; 139(4):517-8. PubMed ID: 6121492
    [No Abstract]   [Full Text] [Related]  

  • 35. Tardive dyskinesia and other clinical consequences of neuroleptic treatment in children and adolescents.
    Gualtieri CT; Quade D; Hicks RE; Mayo JP; Schroeder SR
    Am J Psychiatry; 1984 Jan; 141(1):20-3. PubMed ID: 6140865
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tardive diaphragmatic flutter.
    Burn DJ; Coulthard A; Connolly S; Cartlidge NE
    Mov Disord; 1998 Jan; 13(1):190-2. PubMed ID: 9452356
    [No Abstract]   [Full Text] [Related]  

  • 37. Case report of neuroleptic malignant syndrome with prolonged mental changes and severe dyskinesia.
    Chung YJ; Lee SJ
    Asia Pac Psychiatry; 2018 Mar; 10(1):. PubMed ID: 29464897
    [No Abstract]   [Full Text] [Related]  

  • 38. Why neuroleptic withdrawal in schizophrenia?
    Carpenter WT; Tamminga CA
    Arch Gen Psychiatry; 1995 Mar; 52(3):192-3. PubMed ID: 7872843
    [No Abstract]   [Full Text] [Related]  

  • 39. Clozapine Discontinuation and Malignant Catatonia: A Case Report.
    Kapulsky L; Greiner MG; Daniels JE; Gordon-Elliott JS
    Psychosomatics; 2019; 60(1):75-79. PubMed ID: 29703551
    [No Abstract]   [Full Text] [Related]  

  • 40. Neuroleptic withdrawal in schizophrenic patients.
    Baldessarini RJ; Viguera AC
    Arch Gen Psychiatry; 1995 Mar; 52(3):189-92. PubMed ID: 7872842
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.